Morello Maria, Amoroso Dominga, Losacco Felicia, Viscovo Marco, Pieri Massimo, Bernardini Sergio, Adorno Gaspare
Clinical Biochemistry Department of Laboratory Medicine, Division of Proteins, University Hospital (PTV), 00133 Rome, Italy.
Clinical Pathology and Clinical Biochemistry, Graduate School, Faculty of Medicine, University of Tor Vergata, 00133 Rome, Italy.
Life (Basel). 2023 Jul 28;13(8):1640. doi: 10.3390/life13081640.
A urine test permits the measure of several urinary markers. This is a non-invasive method for early monitoring of potential kidney damage. In COVID-19 patients, alterations of urinary markers were observed. This review aims to evaluate the utility of urinalysis in predicting the severity of COVID-19. A total of 68 articles obtained from PubMed studies reported that (i) the severity of disease was related to haematuria and proteinuria and that (ii) typical alterations of the urinary sediment were noticed in COVID-19-associated AKI patients. This review emphasizes that urinalysis and microscopic examination support clinicians in diagnosing and predicting COVID-19 severity.
尿液检测可以测量多种尿液标志物。这是一种用于早期监测潜在肾脏损伤的非侵入性方法。在新冠肺炎患者中,观察到了尿液标志物的变化。本综述旨在评估尿液分析在预测新冠肺炎严重程度方面的效用。从PubMed研究中获得的68篇文章报告称:(i)疾病严重程度与血尿和蛋白尿有关;(ii)在新冠肺炎相关急性肾损伤患者中发现了尿沉渣的典型变化。本综述强调,尿液分析和显微镜检查有助于临床医生诊断和预测新冠肺炎的严重程度。